4-(3-Aryloxyaryl)quinoline alcohols are liver X receptor agonists

A series of 4-(3-aryloxyaryl)quinolines 5 was prepared as LXR agonists. A series of 4-(3-aryloxyaryl)quinolines with alcohol substituents on the terminal aryl ring was prepared as potential LXR agonists, in which an alcohol group replaced an amide in previously reported amide analogs. High affinity...

Full description

Saved in:
Bibliographic Details
Published inBioorganic & medicinal chemistry Vol. 17; no. 23; pp. 8086 - 8092
Main Authors Bernotas, Ronald C., Kaufman, David H., Singhaus, Robert R., Ullrich, John, Unwalla, Rayomand, Quinet, Elaine, Nambi, Ponnal, Wilhelmsson, Anna, Goos-Nilsson, Annika, Wrobel, Jay
Format Journal Article
LanguageEnglish
Published Amsterdam Elsevier Ltd 01.12.2009
Elsevier
Subjects
Online AccessGet full text

Cover

Loading…
More Information
Summary:A series of 4-(3-aryloxyaryl)quinolines 5 was prepared as LXR agonists. A series of 4-(3-aryloxyaryl)quinolines with alcohol substituents on the terminal aryl ring was prepared as potential LXR agonists, in which an alcohol group replaced an amide in previously reported amide analogs. High affinity LXR ligands with excellent agonist potency and efficacy in a functional model of LXR activity were identified, demonstrating that alcohols can substitute for amides while retaining LXR activity. The most potent compound was 5b which had an IC 50 = 3.3 nM for LXRβ binding and EC 50 = 12 nM (122% efficacy relative to T0901317) in an ABCA1 mRNA induction assay in J774 mouse cells.
Bibliography:ObjectType-Article-1
SourceType-Scholarly Journals-1
ObjectType-Feature-2
content type line 23
ISSN:0968-0896
1464-3391
DOI:10.1016/j.bmc.2009.10.001